The male god of magic capital

Chapter 169 170 Winners and Fools!
Now the A-share account funds of the Luo Family Foundation have reached 6 million.

In the Hong Kong stock account, there are still 2500 million shares of Fuxing Medicine open.

In the past two days, the stock price of Fuxing Medicine in the Hong Kong stock market has rushed to 34 yuan per share. The Roche Family Foundation holds 2500 million shares. The average price of opening positions is 20 Hong Kong dollars per share, and the floating profit per share is 14 Hong Kong dollars. The total floating profit is 3.5 million Hong Kong dollars. The net value has reached 8.5 million Hong Kong dollars.

Very good, no rush to close positions.

Luo Cheng planned to wait for its stock price to reach 50 yuan per share before closing the position.

In the past two days, the stock prices of both the A-share Fuxing Medicine and the Hong Kong stock Fuxing Medicine have been very strong.

The stock price of A-share Fuxing Medicine has stabilized at 90 yuan per share, and the next step is to rush to 100 yuan per share.

The stock price of Fuxing Pharmaceutical, a Hong Kong stock market, will hit the position of 40 Hong Kong dollars per share, and Luo Cheng is looking forward to it.

"I hope that Fuxing Medicine, a Hong Kong stock, can reach 40 Hong Kong dollars a share, or even 50 Hong Kong dollars a share."

The share capital of the Hong Kong stock Fuxing Pharmaceutical is not large, and the daily trading volume is not high. At that time, it was very difficult for Luo Cheng to open a position.

At the beginning, Luo Cheng only bought 1000 million shares, which caused the stock price to rise a lot. The next 1500 million shares were bought from Swire Securities at a market price of HK$20 per share. At that time, Swire Securities was not optimistic about the revival Medicine, I thought its stock price would fall to 14 Hong Kong dollars per share, but now the stock price of Fuxing Medicine has risen to 34 Hong Kong dollars per share, haha, I don’t know if Swire Securities regrets it?
If you want to come to Swire Securities, you don't care about this little money. After all, behind Swire Securities is the Swire Group, a large consortium in Xiangjiang.

Swire Securities sold 1500 million shares to Luo Cheng through Huang Hanxing, the president of Huaxia District of Dah Sing Bank. Before that, Huang Hanxing thought that he was a high-level receiver. Hehe, regret it now?

At that time, Swire Securities must first find Dah Sing Fund to take over the 1500 million shares of Fuxing Pharmaceutical. As a result, Huang Hanxing refused to take it and recommended Luo Cheng to take it. Luo Cheng said nothing at the time.

Now he holds 2500 million shares, worth 8.5 million Hong Kong dollars. If Luo Cheng wants to ship, the stock price needs to rise above 40 Hong Kong dollars per share. Of course, what he expects is that the stock price of Fuxing Medicine can reach more than 50 Hong Kong dollars per share.

At this time, the phone rang, and it was Huang Hanxing from Dah Sing Bank who answered the phone.

Luo Cheng asked: "Boss Huang, what's the matter?"

Huang Hanxing smiled and said, "Mr. Luo, I have two things to ask of you."

Luo Cheng: "Speak, I'll listen."

Huang Hanxing said: "Our Daxin Fund wants to buy the shares of Pien Tze Huang Company and Aier Ophthalmology Company held by your Chengtian Public Fund. If the price is the market price, what is Mr. Luo's opinion?"

The net value of Chengtian Public Fund has recently increased, and now its scale is nearly 500 billion. 90% of its stock assets are heavily held in 20 stocks in the medical sector, with an average allocation of nearly 22.5 billion per stock.

This Daxin Fund has taken a fancy to the shares of Pien Tze Huang Company and Aier Ophthalmology Company held by Chengtian Public Fund. Could it be that it will do something next?
Luo Cheng immediately kept an eye on it.

The 20 medical stocks held by Chengtian Public Fund will not be sold.

And in the future, Chengtian Private Equity Fund will aggressively sell the shares of Pien Tze Huang Company and Aier Ophthalmology Company.

"Mr. Huang, I'm sorry, our Chengtian Public Fund is not planning to sell the shares of Pien Tze Huang Company and Aier Ophthalmology Company. If you Daxin Fund wants to buy the shares of these two companies, just buy them directly in the secondary stock market. Their daily trading volume is very large, and Chengtian Public Fund only holds 22.5 billion stocks in each of them."

"That's a pity. I thought Mr. Luo was going to sell it, so that our Dah Sing Fund would not have to buy it in the secondary stock market. After all, if you invest in billions or tens of billions, the stock price will grow a lot." Huang Hanxing thought for a while and said: "There is a second thing, that is, Swire Securities wants to buy back the 1500 million shares of Fuxing Medicine that it sold to you before, let me ask you, buy it back at the market price, do you want to buy it back?" How about next?"

Originally, Swire Securities planned to sell the 1500 million shares to him, but he was not optimistic about Fuxing Medicine's prospects. He was optimistic about Fuxing Medicine's rival, Shenzhou Baekje, so he rejected Swire Securities, and then recommended it to Luo Cheng. Luo Cheng is the receiver.

As a result, he did not expect that the stock price of Fuxing Medicine had risen greatly during this period, and the stock price rose to 34 Hong Kong dollars per share. He regretted it to death.

Grandma, she originally wanted Luo Cheng to be the receiver, but she didn't expect that she missed the money and gave Luo Cheng money for nothing.

Luo Cheng said: "Swire Securities can buy it back if you want, but it's not the market price."

Huang Hanxing asked: "Mr. Luo, how much premium do you want for a price?"

Luo Cheng: "40 Hong Kong dollars per share will do."

"What?" Huang Hanxing was shocked: "Now it's only 34 Hong Kong dollars per share, and you want a premium of 6 Hong Kong dollars, which is a premium of 17.6%, which is impossible for Swire Securities to agree to."

Luo Cheng smiled and said: "It's okay, the fundamentals of Fuxing Pharmaceutical are very good now, I will wait for the stock price of Fuxing Pharmaceutical to reach above 40 Hong Kong dollars per share, and then I will slowly close the position. This Swire Securities wants to buy Fuxing Pharmaceutical The stock of pharmaceuticals can be bought slowly in the secondary stock market."

Huang Hanxing suddenly said: "Mr. Luo, how about the price of our Dah Sing Bank's fund in Hong Kong giving you 36 Hong Kong dollars per share?"

Luo Cheng: "Mr. Huang, are you too picky? The stock price of Fuxing Pharmaceutical has such a good prospect. It is very normal for the stock price to rise to 80 Hong Kong dollars in the next year. If I am not short-term, I will not consider the stock price increase at all. When it reaches 40 Hong Kong dollars, I will close the position, and I will just hold it for 1 year."

The prospect of Fuxing Medicine is indeed good, but I don’t know how long it will take for the stock price to rise to HK$80 per share, maybe a year, maybe 2 years!
Luo Cheng will not hold it for a long time.

In one or two years, 1 million will become 2 billion?
He feels slow, and he will choose to leave the market when the stock price of Renaissance Medicine rises to 40 Hong Kong dollars per share, and use the money to invest in other stocks that can make quick money.

Don't want to linger too long on Renaissance Medicine's stock.

Of course, if you want to change to Chengtian Public Fund, you must hold it for a long time. Anyway, the annual rate of return exceeds 15%, which outperforms inflation, which is a good return.

But the Luo Family Foundation is not good, Luo Cheng has high requirements for the Luo Family Foundation, and in the future the Luo Family Foundation will also prepare for Chengtian Holdings to go abroad and rush to the world.

He needs a lot of Hong Kong dollars, and he can earn a lot of Hong Kong dollars quickly to prepare for Chengtian Holdings' acquisition of Hong Kong's listed financial group.

On the phone, Huang Hanxing said regretfully: "Well then, Mr. Luo, the stock price of Fuxing Medicine may fall below 30 Hong Kong dollars tomorrow. I hope you will think about it."

After finishing the phone call, Luo Cheng shook his head, not thinking about it at all.

The stock price of Renaissance Medicine is hitting a new high, and I believe it will soon reach HK$40 per share.

···
The next day, March 3, the stock market opened,

On the Hong Kong stock market, the share price of Fuxing Medicine began to rise.

34.11
34.53
34.81
35.00 position, and then continued to fluctuate here until the morning market closed.

After the market opened in the afternoon, the stock price rose slowly.

35.15
35.24
35.76
·
36.00 position, and then stood firm here until the close.

The Hong Kong stock account of the Luo Family Foundation has a floating profit of 4 million Hong Kong dollars, and its net worth has reached 9 million Hong Kong dollars, which will soon break through 10 billion Hong Kong dollars.

"Tomorrow it should break 10 billion Hong Kong dollars."

"It's only 4 Hong Kong dollars higher."

Today, the bull side in the market is very stable, pushing up the stock price step by step. The stock price of Fuxing Medicine will definitely reach 40 Hong Kong dollars per share tomorrow. If it does not reach 40 Hong Kong dollars per share tomorrow, it will definitely be the day after tomorrow.

Thinking of Huang Hanxing saying that he would buy the Fuxing Pharmaceutical stock in his hand for 36 Hong Kong dollars a share, Luo Cheng laughed.

In the evening, Luo Cheng was having dinner at Jiayuan Boutique Hotel, when the phone rang, it was Huang Hanxing.

"Mr. Luo, the stock price of Fosun Pharma has risen again today, how about 38 Hong Kong dollars a share, I will buy all the shares of Fuxing Pharmaceutical in your hand."

The price given by Huang Hanxing was 2 Hong Kong dollars higher than the market price again. Luo Cheng laughed, and insisted: "Mr. Huang, 40 Hong Kong dollars per share, 2500 million shares will be sold to you."

Huang Hanxing: "."

"Mr. Luo, let me tell you that when the stock price of Fuxing Medicine rises to 40 Hong Kong dollars a share, you will start to close your position. If you calculate the shipment of 10 billion Hong Kong dollars, the stock price will fall a lot. I will give you 38 Hong Kong dollars a share." The stock is already very good, don't be too greedy!"

Luo Cheng said with a smile: "Mr. Huang, then you can just buy it in the market. I will wait for the stock price to reach 40 Hong Kong dollars per share and then slowly sell. Maybe the stock price of Fuxing Medicine will rise to 40 Hong Kong dollars per share tomorrow." .”

Huang Hanxing: "Fuxing Pharmaceutical's stock price will definitely fall tomorrow!"

At 10:[-] p.m., Goldman Sachs released its recent investment strategy highlights, believing that the business of Fuxing Pharmaceuticals covers the entire pharmaceutical and health industry chain, including pharmaceutical manufacturing and research and development, medical services, medical equipment and medical diagnosis, pharmaceutical distribution and retail, etc. Focus on pharmaceutical manufacturing and research and development, and focus on medical services.

With the clinical application of innovative drugs, the spin-off and listing of subsidiaries, and the completion of overseas acquisitions to promote the company's entire health industry chain and globalization process, it can be seen that the integration of Fuxing Pharmaceutical's assets has accelerated significantly, and the company's early layout has begun to be profitable. Make a contribution and gradually enter the harvest period. The stock price will rise to HK$50 a share in the second half of the year.

The next day, March 3th, Thursday.

The share price of Renaissance Medicine started to rise again.

36.75
37.12
37.84
38.14
39.48
40.00 position, and then stood firm, and did not fall below 40 Hong Kong dollars per share until the close.

The Luo family foundation has a floating profit of 5 million Hong Kong dollars, and the net value of the account is as high as 10 billion Hong Kong dollars.

Huang Hanxing called again: "Mr. Luo, you won. How about the price of 40 Hong Kong dollars per share? If you close the position, the stock price will also drop a lot. The average price must be lower than 40 Hong Kong dollars per share."

Luo Cheng yawned: "Okay, then 40 Hong Kong dollars a share."

Then the Luo family foundation sold 2500 million shares to Dah Sing Fund, and received 10 billion Hong Kong dollars.

"Mr. Huang, I remember that when you recommended me to buy the 1500 million shares of Fuxing Pharmaceutical in the hands of Swire Securities, it was only 20 Hong Kong dollars a share. At that time, you definitely didn't want to buy the stocks in the hands of Swire Securities, so you recommended it to me. , Hey, I thought I took over the order at a high position, but I didn’t expect that I sold it for 40 Hong Kong dollars a share, and I have doubled my profit, which is really a surprise.” Luo Cheng laughed and said: “Mr. Huang, it will be such a good thing in the future , remember to find me again."

Huang Hanxing was so ashamed and ashamed!
Luo Cheng is the winner, he is a fool!

He gritted his teeth and said hastily, "Definitely, definitely."

(End of this chapter)